<DOC>
	<DOC>NCT00984529</DOC>
	<brief_summary>The purpose of this study is to determine whether treatment with candesartan cilexetil for at least 6 months in patients with chronic heart failure improves clinical signs and symptoms of chronic heart failure.</brief_summary>
	<brief_title>Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Signs and Symptoms</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>Patients with diagnosed chronic heart failure Patients treated for at least 6 months with candesartan cilexetil Signed Informed consent Hypersensitivity to candesartan cilexetil Pregnancy / lactation Severe hepatic impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Chronic heart failure</keyword>
	<keyword>candesartan cilexetil</keyword>
	<keyword>clinical signs</keyword>
	<keyword>symptoms</keyword>
</DOC>